Form D — NEURONA THERAPEUTICS, INC
0001443321-25-000001 · filed 2025-04-04
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $101,711,423
- Total sold
- $101,711,423
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- NEURONA THERAPEUTICS, INC
- CIK
- 1443321
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 170 HARBOR WAY
SOUTH SAN FRANCISCO, CA 94080 - Phone
- 650-676-4182
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Cory Nicholas · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
-
James Stutz · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
-
Tim Kutzkey · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Leo Guthart · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Ray Kelleher · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Brad Margus · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Erica Whittaker · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Peter Svennilson · DirectorSouth San Francisco, CA Find on LinkedIn ↗
View original on SEC EDGAR.